Top

Knight Therapeutics Inc.

TSX Exchange | Jun 6, 2020, 7:01 AM EDT | Real-time price

GUD $ 7.20 RT
CHANGE
-0.19 (-2.571%)
VOLUME
645,276
Day Low: 7.19
Day High: 7.46

News Headlines for Knight Therapeutics Inc.loading

    Wednesday, May 27, 2020
    Knight to Present at the Jefferies 2020 Virtual Global Healthcare Conference
    - GlobeNewswire , 5:01 PM EDT
    Monday, April 20, 2020
    Knight Announces the Re-Launch of Trelstar® in Canada
    - GlobeNewswire , 7:30 AM EDT
    Friday, April 17, 2020
    Knight Therapeutics Announces Approval of IBSRELA(TM) in Canada
    - GlobeNewswire , 7:30 AM EDT
    Thursday, April 16, 2020
    Knight Therapeutics Inc. Announces Triumvira Loan Repayment
    - GlobeNewswire , 7:00 AM EDT
    Wednesday, April 15, 2020
    Knight Therapeutics Inc. Announces Completion of its Normal Course Issuer Bid
    - GlobeNewswire , 8:30 PM EDT
    Thursday, April 9, 2020
    Knight Therapeutics Files Annual Information Form
    - GlobeNewswire , 10:00 PM EDT
    Monday, March 30, 2020
    Knight Therapeutics Reports Fourth Quarter and Year End 2019 Results
    - GlobeNewswire , 5:01 PM EDT
    Monday, March 16, 2020
    Knight Announces Closing of Separation Agreement
    - GlobeNewswire , 5:00 PM EDT
    Wednesday, January 8, 2020
    Knight Partners with Debiopharm for the Commercialization of Trelstar® in Canada
    - GlobeNewswire , 8:00 AM EST
    Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia. See the QuoteMedia Terms of Use.